| |
| Pharmacology |
|
PHARM-1
|
Avila, Amy
M. (NIGMS)
|
A. Avila, C. Sumner, N. Woodling, L. Kernochan, P. Hartenstein, K. Fischbeck
|
| |
Regulation of the Survival of Motor Neuron (SMN) Gene with Valproic Acid and 5-aza-2'-deoxycytidine: Possible Treatments for Spinal Muscular Atrophy (SMA)
|
| |
|
PHARM-2
|
Comer, Frank
I. (NIGMS)
|
F.I. Comer, C.K. Lippincott, J.J. Masbad, and C.A. Parent
|
| |
PH Domain Function - Not Just For Lipids Anymore
|
| |
|
PHARM-3
|
Cox, Constance
Ann (NEI)
|
C.A. Cox, M.John-Aryankalayil, C.Jaworski, P.Russell, T.Gray, K.Freedman, N.Dushku, T.W.Reid, D.Carper
|
| |
Doxycycline Inhibits the Migration of Cultured Human Pterygial Epithelial Cells
|
| |
|
PHARM-4
|
Daly, John
W. (NIDDK)
|
J.W. Daly, H.M. Garraffo, T.F. Spande
|
| |
Bioactive Alkaloids from Amphibian Skin
|
| |
|
PHARM-5
|
Dou, Jingtao
(NIMH)
|
J. Dou, J. Zhou, G.Baiardi ,I. Armando, J.M. Saavedra
|
| |
Angiotensin II AT1 Receptor Antagonist Decreases Glucocorticoid and Mineralocorticoid Receptor Expression in Brain Microvessels of Spontaneously Hypertensive Rats
|
| |
|
PHARM-6
|
Dunbar, Lisa
A. (NIGMS)
|
L.A. Dunbar, R.J. Wenthold
|
| |
Molecular Interactions Involved in the Regulation of Glutamate Receptor Trafficking by the Exocyst
|
| |
|
PHARM-7
|
Greiner, Elisabeth
(NIDDK)
|
E. Greiner, T.L. Boos, T.E. Prisinzano, M.G. De Martino, B. Zeglis, C.M. Dersch, J. Marcus, J.S. Partilla, R.B. Rothman, A.E. Jacobson, K.C. Rice
|
| |
Design and Synthesis of Novel Cocaine Abuse Therapeutics: Novel GBR 12909 Analogues with Customized Binding Affinities at the Monoamine Transporters
|
| |
|
PHARM-8
|
Kagan, Benjamin
L. (NIDDK)
|
B.L. Kagan, S. Cho, J.A. Blackford Jr., D. Szapary, S.S. Simons Jr.
|
| |
The Role of N-Terminal and C-Terminal Sequences of the Glucocorticoid Receptor in the Modulation of the Dose-Response Curve and Partial Agonist Activity of Receptor Complexes by Ubc9
|
| |
|
PHARM-9
|
Mitchell, Drake
C. (NIAAA)
|
B.W. Bailey, J. Lewis, N. Swenby, D.C. Mitchell
|
| |
Gender-Specific Effect of N-3 Deficient Diet on Brain Phospholipid Composition and Bezodiazepine Binding by GABA(A) in Rats
|
| |
|
PHARM-10
|
Prybylowski, Kate
L. (NIDCD)
|
K. Prybylowski, K. Chang, S. Vicini, R.J. Wenthold
|
| |
Synaptic NMDA Receptor Number is Regulated by a Balance Between Anchoring Mediated by PDZ Binding and Endocytosis Mediated by AP-2
|
| |
|
PHARM-11
|
Quimby, Byrn
Booth (NIGMS)
|
B. B. Quimby, V. Yong-gonzalez, A. Strunnikov, and M. Dasso
|
| |
The PML Protein has SUMO E3-like Activity in Yeast
|
| |
|
PHARM-12
|
Rao, V Ashutosh
(NCI)
|
V.A. Rao, P.S. North, I.D. Hickson, Y. Pommier
|
| |
Functional Status of the Bloom’s Syndrome Protein (BLM) Alters Topoisomerase I-DNA Cleavage Complex Formation and Repair Response to Camptothecin
|
| |
|
PHARM-13
|
Robinson, Michael
R. (NEI)
|
M.R. Robinson, A.J. Barrett, R. Childs, S. Pavletic, A. Djalilian, W. O’Donnell, P. Yuan H. Kim, R. Lutz, M. Tremblay, K.G. Csaky
|
| |
A Novel Sustained-Release Subconjunctival Cyclosporine Implant for Ocular Graft-vs-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
|
| |
|
PHARM-14
|
Swisher, Jennifer
F.A. (NIDCR)
|
J.F.A. Swisher, W. Chen, S.M. Wahl
|
| |
TGF-beta at the Mitochondria: Potential Mechanisms for its Import and Function
|
| |
|
PHARM-15
|
Young, Sharla
F. (NIGMS)
|
S.F. Young and G. Aguilera
|
| |
Dimerization of Vasopressin Receptor Type 1b
|
| |
|
PHARM-16
|
Zhou, Jin
(NIMH)
|
J. Zhou, H. Ando, M. Macova, J. Dou and J.M. Saavedra
|
| |
Angiotensin AT1 Antagonist Decreases Inflammation in Brain Microvessels from Hypertensive Rats
|
| |